142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

300303
Ethics, Individualism and the Medicalization of Public Health

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 12:54 PM - 1:06 PM

Daniel Goldberg, J.D., Ph.D , Department of Bioethics & Interdisciplinary Studies, The Brody School of Medicine, East Carolina University, Greenville, NC
The central claim of this paper is that dominant practices in U.S. public health are highly individualized and medicalized, and that this state of affairs is ethically problematic.  The paper extends the author’s body of work regarding the influence and deficiencies of what can be termed ‘methodological individualism’ in U.S. public health to a larger discussion about the medicalization of public health practice and policy in the 20th c. U.S.  The paper begins with an historical argument regarding the shift from the early U.S. public health leaders’ emphasis on social reform to a model of public health that emphasized medical services and interventions (i.e., laboratory techniques, clinical screening, etc.).  The next section of the paper introduces the ethical framework used to evaluate that shift, which is Powers and Faden’s health sufficiency model of social justice.  Powers and Faden’s “twin aims theory” suggests that ethically optimal public health policy should maximize two consequences: improvement in absolute population health and compression of health inequities.  Unfortunately, robust epidemiologic evidence demonstrates that public health interventions targeted at changing individual health behaviors are unlikely to improve substantially overall population health.  Worse yet, the same evidence suggests that individualized and medicalized interventions may actually expand health inequities.  In both respects, such interventions thereby contravene Powers and Faden’s model of social justice.  The paper concludes with a positive argument regarding what model of public health ought to replace the individualized and medicalized version: one that prioritizes collective action on upstream, macrosocial determinants of health.  In its emphasis on collective action and structural remedies, such a model eschews pathways of both individualism and medicalization.  This section of the paper provides practical examples of interventions that embody such an approach and are likely to advance the twin aims theory, including intensive investment in early childhood development and stigma reduction policies and programs.  Ultimately, the historical argument illustrates that this broader model of public health is hardly novel, but rather reflects a return to the true roots of U.S. public health policy, a practice grounded in broad-based social reform.

Learning Areas:

Ethics, professional and legal requirements
Public health or related public policy

Learning Objectives:
Describe the shift in focus from early U.S. public health reformers to dominant practices in 20th c. U.S. public health. Explain why public health interventions that focus on individual behavioral change and clinical services are unlikely to satisfy mandates of social justice. Identify two examples of public health interventions that, by emphasizing collective action on macrosocial determinants of health, maximize social justice.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a public health ethicist with particular expertise on the deficiencies in methodological individualism in public health practice and policy. I have multiple refereed presentations and peer-reviewed publications in the field, including but not limited to topics such as the social determinants of health, broad vs. narrow models of public health, and social justice in public health law and policy.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.